Published in
Wiley, British Journal of Haematology, 2(193), p. 325-338, 2021
DOI: 10.1111/bjh.17326
Links
Tools
Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study
Journal article published in 2021 by
Stephan Stilgenbauer 
,
Francesc Bosch,
Osman Ilhan,
Jens Kisro,
Béatrice Mahé,
Eva Mikuskova,
Dzhelil Osmanov,
Gianluigi Reda,
Sue Robinson,
Eugen Tausch,
Mehmet Turgut,
Marcin Wójtowicz,
Sebastian Böttcher,
Thomas Perretti,
Peter Trask
and other authors.
,
Francesc Bosch,
Osman Ilhan,
Jens Kisro,
Béatrice Mahé,
Eva Mikuskova,
Dzhelil Osmanov,
Gianluigi Reda,
Sue Robinson,
Eugen Tausch,
Mehmet Turgut,
Marcin Wójtowicz,
Sebastian Böttcher,
Thomas Perretti,
Peter Trask
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 